You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

SMC approve Johnson & Johnson’s systemic light chain amyloidosis therapy

The Janssen Pharmaceutical Companies of Johnson & Johnson has welcomed the decision by the Scottish Medicines Consortium (SMC) to accept Darzalex.